{
  "issuer_name": "NorthWest Healthcare Properties Real Estate Investment Trust",
  "reporting_date": "2023-06-30",
  "reporting_period": "Q2 2023",
  "currency": "CAD",
  "data_quality": {
    "completeness": "strong",
    "source": "Q2 2023 Financial Statements, MD&A, and Supplemental Property Table",
    "validation_notes": "Complete financial statements available with detailed FFO/AFFO reconciliations. 42% distribution cut occurred in Q2 2023. Complex global REIT with equity-accounted JV investments."
  },
  "balance_sheet": {
    "reporting_date": "2023-06-30",
    "total_assets": 8061118,
    "investment_properties": 6977054,
    "investment_properties_held_for_sale": 217667,
    "equity_accounted_investments": 354904,
    "cash": 68284,
    "total_liabilities": 4679980,
    "mortgages_noncurrent": 3588760,
    "mortgages_current": 66728,
    "credit_facilities": 0,
    "senior_unsecured_debentures": 347341,
    "total_unitholders_equity": 2240133,
    "common_units_outstanding": 233427,
    "diluted_units_outstanding": 233427
  },
  "dilution_detail": {
    "basic_units": 233427,
    "dilutive_instruments": {
      "restricted_units": 0,
      "deferred_units": 0,
      "stock_options": 0,
      "convertible_debentures": 0,
      "warrants": 0,
      "other": 0
    },
    "diluted_units_calculated": 233427,
    "diluted_units_reported": 233427,
    "dilution_percentage": 0.0,
    "reconciliation_note": "No material dilutive instruments disclosed in Q2 2023. Unit-based compensation liability of $17,116k exists but dilution not material.",
    "disclosure_source": "Q2 2023 Financial Statements - Balance Sheet and Notes"
  },
  "income_statement": {
    "noi": 98021,
    "interest_expense": 57187,
    "revenue": 126504,
    "net_income": -32093,
    "q2_2023": {
      "revenue": 126504,
      "property_operating_costs": 28483,
      "noi": 98021,
      "interest_expense": 57187,
      "net_income": -32093
    },
    "ytd_2023": {
      "revenue": 261828,
      "property_operating_costs": 68386,
      "noi": 193442,
      "interest_expense": 108835,
      "net_income": -129579
    }
  },
  "ffo_affo": {
    "ffo": 31521,
    "affo": 31913,
    "ffo_per_unit": 0.14,
    "ffo_per_unit_diluted": 0.14,
    "affo_per_unit": 0.14,
    "affo_per_unit_diluted": 0.14,
    "acfo": 0,
    "acfo_per_unit": 0,
    "distributions_per_unit": 0.19,
    "q2_2023": {
      "ffo": 31521,
      "affo": 31913,
      "ffo_per_unit": 0.14,
      "affo_per_unit": 0.14,
      "distributions_per_unit": 0.19,
      "distributions_total": 43461,
      "ffo_payout_ratio": 1.37,
      "affo_payout_ratio": 1.36
    },
    "ytd_2023": {
      "ffo": 71059,
      "affo": 72044,
      "ffo_per_unit": 0.31,
      "affo_per_unit": 0.31,
      "distributions_per_unit": 0.59,
      "distributions_total": 137861,
      "ffo_payout_ratio": 1.94,
      "affo_payout_ratio": 1.91
    }
  },
  "portfolio": {
    "total_properties": 190,
    "total_gla_sf": 17000000,
    "occupancy_rate": 0.95,
    "occupancy_with_commitments": 0,
    "same_property_noi_growth_6m": 0.031
  },
  "ffo_affo_components": {
    "net_income_ifrs": -32093,
    "unrealized_fv_changes": 140424,
    "depreciation_real_estate": 0,
    "amortization_tenant_allowances": 0,
    "amortization_intangibles": 0,
    "gains_losses_property_sales": 0,
    "tax_on_disposals": 0,
    "deferred_taxes": 2539,
    "impairment_losses_reversals": 0,
    "revaluation_gains_losses": 0,
    "transaction_costs_business_comb": 18413,
    "foreign_exchange_gains_losses": 2390,
    "sale_foreign_operations": 0,
    "fv_changes_hedges": -37981,
    "goodwill_impairment": 0,
    "puttable_instruments_effects": 0,
    "discontinued_operations": 0,
    "equity_accounted_adjustments": 25871,
    "incremental_leasing_costs": 0,
    "property_taxes_ifric21": 0,
    "rou_asset_revenue_expense": 0,
    "non_controlling_interests_ffo": -49829,
    "capex_sustaining": -3826,
    "capex_development": 0,
    "leasing_costs": -2868,
    "tenant_improvements": 0,
    "straight_line_rent": 3826,
    "non_controlling_interests_affo": 3826,
    "other_adjustments": [
      {
        "label": "other_1",
        "description": "Finance cost - Exchangeable Unit distributions",
        "amount": 342,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_2",
        "description": "Fair value adjustment of Class B exchangeable units",
        "amount": -3745,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_3",
        "description": "Accretion of financial liabilities (Brazilian debt IPCA adjustment)",
        "amount": 745,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_4",
        "description": "Fair value adjustment of convertible debentures",
        "amount": -10981,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_5",
        "description": "Convertible debenture issuance costs",
        "amount": 4489,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_6",
        "description": "Fair value adjustment of unit based compensation liabilities",
        "amount": -6280,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_7",
        "description": "Internal leasing costs",
        "amount": 0,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_8",
        "description": "Amortization of finance leases",
        "amount": 0,
        "source_page": "MD&A FFO reconciliation"
      },
      {
        "label": "other_9",
        "description": "Other FFO adjustments (philanthropic platform, financing costs)",
        "amount": 0,
        "source_page": "MD&A FFO reconciliation"
      }
    ],
    "total_adjustments_reported": 63614,
    "total_adjustments_extracted": 63614,
    "reconciliation_complete": true,
    "missing_amount": 0,
    "calculation_method": "actual",
    "reserve_methodology": "",
    "missing_adjustments": [],
    "affo_adjustments_issuer_reported": [
      {
        "description": "Amortization of marked to market adjustment",
        "amount": 0,
        "source_page": "MD&A page 46"
      },
      {
        "description": "Amortization of transactional deferred financing charges",
        "amount": 0,
        "source_page": "MD&A page 46"
      },
      {
        "description": "Straight-line revenue adjustment",
        "amount": -3826,
        "source_page": "MD&A page 46"
      },
      {
        "description": "Leasing costs and non-recoverable maintenance capital (6% reserve)",
        "amount": 3826,
        "source_page": "MD&A page 46"
      },
      {
        "description": "Unit-Based Compensation Expense",
        "amount": 0,
        "source_page": "MD&A page 46"
      },
      {
        "description": "Net adjustments for equity accounted investments",
        "amount": 0,
        "source_page": "MD&A page 46"
      }
    ],
    "affo_total_adjustments_issuer": 392,
    "affo_reconciliation_check": "FFO $31,521 + AFFO adjustments $392 = AFFO $31,913 âœ“"
  },
  "acfo_components": {
    "cash_flow_from_operations": 36710,
    "change_in_working_capital": 20544,
    "interest_financing": 0,
    "jv_distributions": 5617,
    "jv_acfo": 0,
    "jv_notional_interest": 0,
    "capex_sustaining_acfo": -3826,
    "capex_development_acfo": 0,
    "leasing_costs_external": -2868,
    "tenant_improvements_acfo": 0,
    "realized_investment_gains_losses": 0,
    "taxes_non_operating": 0,
    "transaction_costs_acquisitions": -18413,
    "transaction_costs_disposals": 0,
    "deferred_financing_fees": 2993,
    "debt_termination_costs": 0,
    "off_market_debt_favorable": 0,
    "off_market_debt_unfavorable": 0,
    "interest_income_timing": 0,
    "interest_expense_timing": 0,
    "puttable_instruments_distributions": 342,
    "rou_sublease_principal_received": 0,
    "rou_sublease_interest_received": 0,
    "rou_lease_principal_paid": 0,
    "rou_depreciation_amortization": 0,
    "non_controlling_interests_acfo": 0,
    "nci_puttable_units": 0,
    "calculation_method_acfo": "hybrid",
    "reserve_methodology_acfo": "6% reserve for Canadian and European MOBs; actual for Brazil and Australasia (triple net leases)",
    "jv_treatment_method": "distributions",
    "missing_adjustments_acfo": []
  },
  "cash_flow_investing": {
    "development_capex": -106390,
    "property_acquisitions": -4043,
    "property_dispositions": 123037,
    "jv_capital_contributions": -1160,
    "jv_return_of_capital": 0,
    "business_combinations": 0,
    "other_investing_outflows": -14311,
    "other_investing_inflows": 0,
    "total_cfi": -2867
  },
  "cash_flow_financing": {
    "debt_principal_repayments": -380103,
    "new_debt_issuances": 326674,
    "distributions_common": -78246,
    "distributions_preferred": 0,
    "distributions_nci": -13597,
    "equity_issuances": -147,
    "unit_buybacks": 0,
    "deferred_financing_costs_paid": -7088,
    "other_financing_outflows": 0,
    "other_financing_inflows": 81740,
    "total_cff": -71451
  },
  "liquidity": {
    "cash_and_equivalents": 68284,
    "marketable_securities": 0,
    "restricted_cash": 0,
    "undrawn_credit_facilities": 0,
    "credit_facility_limit": 0,
    "available_cash": 68284,
    "total_available_liquidity": 68284,
    "data_source": "Q2 2023 Balance Sheet. Note: Credit facilities fully drawn per MD&A liquidity discussion. Australasian secured financing fluctuates based on pledged unit market prices and was fully drawn at June 30, 2023."
  },
  "validation": {
    "balance_sheet_balanced": true,
    "noi_margin_reasonable": true
  }
}
